BOMBESIN
Diagnostic Imaging
Lantheus Biosciences Ltd.protein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Diagnostic Imaging cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Psma-Hbed-Cc Telix Pharmaceuticals (Innovations) Pty Limited | Phase 3 | B |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →